Lenanamo (Lenalidomide) 10 mg / 25 mg - 30 capsules

Lenanamo (Lenalidomide) 10 mg / 25 mg

Lenanamo contains Lenalidomide, an immunomodulatory and anti-cancer medication manufactured by BDR Pharmaceuticals. It is primarily used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma.

Lenalidomide works by affecting the immune system and inhibiting the growth of cancer cells. It helps slow down or stop the progression of the disease, reduce abnormal cell production, and enhance the body’s natural immune response.

Indications

• Multiple Myeloma (in combination with dexamethasone)
• Myelodysplastic Syndromes associated with deletion 5q abnormality
• Mantle Cell Lymphoma (after prior therapy)

Dosage & Administration

Lenanamo is available in 10 mg and 25 mg capsules.
The dosage is determined by a healthcare professional based on the patient’s condition, treatment response, and tolerability. Capsules should be swallowed whole with water and not broken or chewed.

Side Effects

Common side effects may include fatigue, nausea, diarrhea, rash, dizziness, and low blood counts (anemia, neutropenia). Regular blood tests are recommended during treatment.

Precautions

• Use only under medical supervision.
• Contraindicated in pregnancy – Lenalidomide can cause severe birth defects.
• Effective contraception must be used during and after treatment.
• Inform your doctor about any existing medical conditions or medications.

Manufacturer

BDR Pharmaceuticals International Pvt. Ltd.